Cocaethylene: Mixing Cocaine and Alcohol

Dr. Sheridan Walter
Dr. Jennie Stanford
Written by Dr. Sheridan Walter on 02 April 2025
Medically reviewed by Dr. Jennie Stanford on 07 April 2025

Mixing cocaine and alcohol leads to the formation of cocaethylene, a toxic compound that remains in the body longer and intensifies harmful effects. This combination significantly increases the risk of heart complications, liver damage, seizures, and overdose. Understanding cocaethylene's dangers is crucial for recognizing the risks of polysubstance use and making informed health decisions.

Key takeaways:
  • Cocaethylene is a toxic byproduct formed when cocaine and alcohol are consumed together, increasing health risks beyond those of either substance alone.
  • It prolongs and amplifies cocaine’s effects but also significantly raises the likelihood of heart damage, liver failure, seizures, and sudden death.
  • Polysubstance use involving cocaethylene can impair judgment, increase addiction risk, and heighten the potential for overdose and other life-threatening outcomes.
a photo of a manicured hand on a table holding up a rolled up dollar bill, there's also powdered cocaine and alcohol on the table

What is cocaethylene?

Cocaethylene is a psychoactive and toxic byproduct that forms in the liver when alcohol and cocaine are used together. Usually, cocaine is broken down by enzymes through a process called hydrolysis. However, when alcohol is present, it alters this process through transesterification, creating the compound cocaethylene.

Cocaethylene can be dangerous because it shares many of cocaine’s stimulating and euphoric effects, and it has a longer half-life and greater toxicity. Cocaethylene significantly increases the risk of heart problems, seizures, liver damage, and sudden death. Studies demonstrate that its combined effects on the heart and central nervous system (CNS) are more severe than those of cocaine alone.

Cocaethylene can also impair a person’s judgment, specifically their ability to recognize how intoxicated they are. Masking the sedative effects of alcohol encourages binge drinking and further risky behavior, such as continued cocaine use, which increases the potential for overdose and fatal accidents or outcomes.

How do cocaine and alcohol create cocaethylene in the body?

Cocaethylene is formed in the body when someone consumes cocaine and alcohol at the same time. The body breaks down cocaine through natural processes in the liver. But when alcohol is present, it changes the way cocaine is metabolized, leading to the creation of cocaethylene.

When alcohol is in the bloodstream, it triggers a reaction in the liver known as transesterification. Instead of breaking cocaine down into its usual byproducts, the liver combines ethanol (alcohol) with cocaine to form cocaethylene. This process is driven by enzymes in the liver that alter cocaine’s normal breakdown pathway.

Effects of cocaethylene

Cocaethylene carries more significant health risks:

Cardiovascular effects:

  • Increased heart rate
  • High blood pressure
  • Chest pain or discomfort
  • Coronary vasospasm → Sudden narrowing of the heart’s blood vessels
  • Myocardial ischemia → Lack of oxygen to muscles of the heart
  • Heart attack
  • Cerebrovascular disease → Impaired blood flow within vessels, which can lead to strokes.
  • Ventricular arrhythmias → Abnormal, fast, or irregular heartbeats that start in the lower chambers of the heart, called the ventricles
  • Sudden cardiac death → Unexpected death caused by a sudden loss of heart function

 CNS effects:

  • Intense alertness
  • Euphoria
  • Seizures
  • Agitation
  • Reduced awareness of intoxication

Liver damage:

  • Acute liver inflammation and oxidative stress
  • Chronic liver damage

Overdose risk:

  • Cocaethylene may mask alcohol’s sedative effects, causing people to drink more alcohol and use more cocaine than intended.
  • Excess use can significantly raise the risk of overdose and other life-threatening complications.

Psychological effects:

Is cocaethylene more harmful than cocaine or alcohol on their own?

Yes. Data indicates cocaethylene is more toxic than using cocaine or alcohol alone. Cocaethylene remains in the body longer than cocaine, placing greater strains on the heart, liver, and central nervous system. This prolonged presence raises the likelihood of severe complications, such as cardiovascular complications, liver damage, seizures, and even sudden death.

Cocaethylene also masks the sedative effects of alcohol, making users more likely to underestimate their level of intoxication and consume larger quantities of both substances. This dangerous pattern can significantly heighten the risk of overdose and other life-threatening consequences.

How long does cocaethylene stay in your system?

Cocaethylene has a plasma half-life three to five times that of cocaine. It is metabolized in the liver, and its duration of action in the body depends on metabolic factors, such as the percentage of fatty tissue, liver function, and usage patterns.

The half-life of cocaethylene ranges between 2.5–6 hours. Following the rule of drug elimination, cocaethylene can stay in the body for 12.5 to 36 hours. However, its metabolites—such as benzoylecgonine and ecgonine methyl ester—are eliminated more slowly, and they extend the overall detection window.

Cocaethylene is usually detectable in blood and saliva for up to 24 hours after use, but this may vary with individual metabolic rates and other factors. Specialized urine tests are able to detect cocaethylene and its metabolites, and they may show positive results 24–72 hours after use.

Chronic or heavy users may have detectable levels of metabolites beyond this timeframe. Additionally, hair samples can detect cocaethylene for up to 90 days after exposure.

The risks of polysubstance use

Polysubstance use—defined as using multiple substances either at the same time or one after the other—dramatically increases the dangers of substance misuse. It can harm both mental and physical health in several ways.

Table summarizing key risks and consequences of polysubstance use

Risk AreaDescriptionExample/Consequence
Increased risk of overdoseMixing different drugs can cause unpredictable and dangerous effects.
  • Combining opioids and alcohol can severely depress breathing, potentially causing coma or death.
Higher risk of addictionUsing substances together heightens euphoria and cravings.
  • Alcohol can boost cocaine’s effects through cocaethylene, increasing addiction risk.
  • Combined substance use overwhelms the brain, speeding up tolerance and withdrawal symptoms.
Mental health deteriorationPolysubstance abuse worsens existing conditions, like anxiety, depression, and psychosis.
  • Unstable moods, aggression, paranoia, and even suicidal thoughts may occur.
  • Prolonged use can impair memory and cognitive function.
Severe physical health risksThe physical effects of polysubstance abuse depend on which substances are combined.
  • Alcohol and opioids worsen respiratory depression.
  • Alcohol and stimulants can cause heart failure.
  • Harmful combinations can lead to liver toxicity.

The complexity of polysubstance use lies in how substances interact, creating risks that often exceed the sum of their individual effects.

Treatment for polysubstance use disorders

Persons who engage in polysubstance use may present to treatment with significant clinical complexity, as the co-use of substances can increase the risk of adverse drug effects, overdose, and/or co-occurring mental health conditions. People with polysubstance use disorder (PUD) may have poorer treatment outcomes, including continued substance use. 

Different substance combinations may require different treatment approaches. Therefore, identifying common patterns and outcomes of polysubstance use can help customize treatments for practical applications. Effective treatment for PUD comprises comprehensive, tailored, evidence-based approaches.

Successful treatment depends on individualized and multidisciplinary approaches, addressing both the immediate withdrawal and the long-term psychological, social, and physical aspects of addiction that drive PUD.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Bashiri, A., Afshar, P., Shadnia, S., et al. (2022). The Impact of Alcohol and Cocaine Use on Health Outcomes. Frontiers in Neuroscience.
  2. ScienceDirect. (n.d.). Cocaethylene. Topics in Neuroscience. Retrieved from
  3. McCance-Katz, E. F., Price, L. H., McDougle, C. J., et al. (1997). Cocaethylene: Pharmacology and Clinical Implications. American Journal on Addictions,6(1), 35–42.
  4. Althobaiti, Y. S., & Sari, Y. (2016). Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies. Journal of Addiction Research & Therapy, 7(3), 281.
  5. Arias, S. A., Dumas, O., Sullivan, A. F., Boudreaux, E. D., Miller, I., & Camargo, C. A., Jr. (2016). Substance use as a mediator of the association between demographics, suicide attempt history, and future suicide attempts in emergency department patients. Crisis, 37(1).
  6. Andrews, P. (1997). Cocaethylene toxicity. Journal of addictive diseases, 16(3), 75–84.
  7. Pennings, E. J., Leccese, A. P., & Wolff, F. A. (2002). Effects of concurrent use of alcohol and cocaine. Addiction (Abingdon, England), 97(7), 773–783.
  8. Pergolizzi, J., Breve, F., Magnusson, P., K LeQuang, J. A., & Varrassi, G. (2022). Cocaethylene: When Cocaine and Alcohol Are Taken Together. Cureus, 14(2), e22498.
  9. Jones, C. M., Paulozzi, L. J., Mack, K. A., & Centers for Disease Control and Prevention. (2014). Increases in drug overdose deaths involving heroin—28 states, 2010 to 2012. Morbidity and Mortality Weekly Report (MMWR), 63(39), 849–854.
  10. McCance-Katz, E. F., Kosten, T. R., & Jatlow, P. (1998). Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—A multiple-dose study. Biological Psychiatry, 44(4), 250–259.
  11. Klimas, J., Tobin, H., Field, C. A., O'Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., Dunne, C., & Cullen, W. (2014). Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. The Cochrane database of systematic reviews, (12), CD009269.
  12. Connor, J. P., Gullo, M. J., White, A., & Kelly, A. B. (2014). Polysubstance use: diagnostic challenges, patterns of use and health. Current opinion in psychiatry, 27(4), 269–275.
  13. National Institute on Alcohol Abuse and Alcoholism. (n.d.). Alcohol and medication interactions: Potentially dangerous mixes. U.S. Department of Health and Human Services. Retrieved from
  14. Ellis, J. D., Rabinowitz, J. A., Ware, O. D., Wells, J., Dunn, K. E., & Huhn, A. S. (2023). Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study. Journal of Substance Use and Addiction Treatment, 146, 208932.
  15. Lin, L. A., Bohnert, A. S. B., Blow, F. C., Gordon, A. J., Ignacio, R. V., Kim, H. M., & Ilgen, M. A. (2021). Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction (Abingdon, England), 116(1), 96–104.
  16. Mostofi, N., & Collins, S. (2023). Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder. Journal of Addiction Medicine, 17, 574–579.
  17. McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010). Cognitive-Behavioral Therapy for Substance Use Disorders. The Psychiatric Clinics of North America, 33(3), 511.
  18. Kelly, T. M., & Daley, D. C. (2013). Integrated Treatment of Substance Use and Psychiatric Disorders. Social Work in Public Health, 28, 388.

Activity History - Last updated: 07 April 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 01 April 2025 and last checked on 07 April 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related guides